Klara Balint

3.5k total citations · 1 hit paper
20 papers, 2.7k citations indexed

About

Klara Balint is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Klara Balint has authored 20 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Klara Balint's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Developmental Biology and Gene Regulation (4 papers). Klara Balint is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Developmental Biology and Gene Regulation (4 papers). Klara Balint collaborates with scholars based in United States, Switzerland and Greece. Klara Balint's co-authors include George Coukos, Andrea Facciabene, Phyllis A. Gimotty, Andrea Barchetti, C. Blake Gilks, Liping Wang, Xiaohui Peng, Lin Zhang, Priti Lal and Ian S. Hagemann and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Klara Balint

20 papers receiving 2.7k citations

Hit Papers

Tumour hypoxia promotes tolerance and angiogenesis via CC... 2011 2026 2016 2021 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
    2011 1.1k citations Andrea Facciabene, Xiaohui Peng et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klara Balint United States 15 1.4k 1.4k 1.2k 454 226 20 2.7k
Philémon Sirven France 16 1.2k 0.8× 1.5k 1.1× 922 0.8× 563 1.2× 248 1.1× 21 2.5k
Ferdinando Pucci United States 17 1.7k 1.2× 1.2k 0.9× 1.5k 1.3× 738 1.6× 162 0.7× 25 3.1k
Paolo Vignali United States 8 1.1k 0.8× 710 0.5× 697 0.6× 595 1.3× 220 1.0× 17 2.0k
Grégory Driessens Belgium 13 712 0.5× 1.2k 0.9× 1.2k 1.0× 616 1.4× 123 0.5× 35 2.4k
Yoko Oei United States 12 1.9k 1.4× 1.1k 0.8× 1.4k 1.2× 338 0.7× 353 1.6× 17 3.6k
James O. Jones United Kingdom 9 1.3k 0.9× 2.3k 1.7× 842 0.7× 552 1.2× 240 1.1× 18 3.0k
Andrew Deonarine United States 10 884 0.6× 1.5k 1.1× 670 0.6× 324 0.7× 169 0.7× 18 2.2k
Ling-Yuan Kong United States 25 1.5k 1.1× 1.5k 1.1× 1.1k 0.9× 720 1.6× 175 0.8× 30 3.2k
Claire M. Connell United Kingdom 13 877 0.6× 1.7k 1.2× 773 0.7× 360 0.8× 143 0.6× 19 2.4k
Katelyn T. Byrne United States 19 1.5k 1.0× 1.5k 1.1× 506 0.4× 234 0.5× 138 0.6× 30 2.4k

Countries citing papers authored by Klara Balint

Since Specialization
Citations

This map shows the geographic impact of Klara Balint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klara Balint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klara Balint more than expected).

Fields of papers citing papers by Klara Balint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klara Balint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klara Balint. The network helps show where Klara Balint may publish in the future.

Co-authorship network of co-authors of Klara Balint

This figure shows the co-authorship network connecting the top 25 collaborators of Klara Balint. A scholar is included among the top collaborators of Klara Balint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klara Balint. Klara Balint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dafni, U., Silvia Martin Lluesma, Klara Balint, et al.. (2020). Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis. European Journal of Cancer. 142. 63–82. 29 indexed citations
2.
Boudousquié, Caroline, et al.. (2020). Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine. Vaccines. 8(1). 25–25. 14 indexed citations
3.
Boudousquié, Caroline, Klara Balint, Brian J. Stevenson, et al.. (2019). A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma. Journal of Translational Medicine. 17(1). 391–391. 46 indexed citations
4.
5.
Mastelic-Gavillet, Béatris, Klara Balint, Caroline Boudousquié, Philippe O. Gannon, & Lana E. Kandalaft. (2019). Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results. Frontiers in Immunology. 10. 766–766. 146 indexed citations
6.
Facciabene, Andrea, Francesco De Sanctis, Stefano Pierini, et al.. (2017). Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy. OncoImmunology. 6(9). e1326442–e1326442. 56 indexed citations
7.
Chiang, Cheryl Lai-Lai, Klara Balint, George Coukos, & Lana E. Kandalaft. (2015). Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opinion on Biological Therapy. 15(4). 569–582. 27 indexed citations
8.
Zsíros, Emese, János L. Tanyi, Klara Balint, & Lana E. Kandalaft. (2014). Immunotherapy for ovarian cancer. Current Opinion in Oncology. 26(5). 492–500. 30 indexed citations
9.
Zhou, Yu, Houping Ni, Klara Balint, et al.. (2014). Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function. PLoS ONE. 9(6). e100800–e100800. 12 indexed citations
10.
Kandalaft, Lana E., Cheryl Lai-Lai Chiang, János L. Tanyi, et al.. (2013). A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. Journal of Translational Medicine. 11(1). 149–149. 53 indexed citations
11.
Balint, Klara, et al.. (2013). Abstract 1421: Interleukin-22, a protective factor for ovarian cancer during TNFa-induced apoptosis.. Cancer Research. 73(8_Supplement). 1421–1421. 2 indexed citations
12.
Facciabene, Andrea, Xiaohui Peng, Ian S. Hagemann, et al.. (2011). Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature. 475(7355). 226–230. 1094 indexed citations breakdown →
13.
Ni, Houping, Klara Balint, Yu Zhou, et al.. (2011). Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation. Radiation Research. 175(4). 485–492. 13 indexed citations
14.
Pinnix, Chelsea C., John Tayu Lee, Zhaojun Liu, et al.. (2009). Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes. Cancer Research. 69(13). 5312–5320. 94 indexed citations
15.
Balint, Klara, et al.. (2008). Role of Vascular Leukocytes in Ovarian Cancer Neovascularization. Advances in experimental medicine and biology. 622. 273–280. 10 indexed citations
16.
Buckanovich, Ronald J., Andrea Facciabene, Sarah Kim-Hellmuth, et al.. (2007). Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Medicine. 14(1). 28–36. 430 indexed citations
17.
Fukunaga‐Kalabis, Mizuho, Gabriela Martínez, Zhaojun Liu, et al.. (2007). Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene. 27(18). 2552–2560. 51 indexed citations
18.
19.
20.
Balint, Klara. (2005). Activation of Notch1 signaling is required for  -catenin-mediated human primary melanoma progression. Journal of Clinical Investigation. 115(11). 3166–3176. 268 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philémon Sirven Breakdown of academic impact, for papers by Ferdinando Pucci Breakdown of academic impact, for papers by Paolo Vignali Breakdown of academic impact, for papers by Grégory Driessens Breakdown of academic impact, for papers by Yoko Oei Breakdown of academic impact, for papers by James O. Jones Breakdown of academic impact, for papers by Andrew Deonarine Breakdown of academic impact, for papers by Ling-Yuan Kong Breakdown of academic impact, for papers by Claire M. Connell Breakdown of academic impact, for papers by Katelyn T. Byrne
Rankless by CCL
2026